Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Article Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Team
    • Feedback
    • Reprints
    • Impact Factor
    • Editorial Fellowship Application Process
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Article Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Team
    • Feedback
    • Reprints
    • Impact Factor
    • Editorial Fellowship Application Process
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
Dialysis
You have accessRestricted Access

Relative Contribution of Residual Renal Function and Peritoneal Clearance to Adequacy of Dialysis: A Reanalysis of the CANUSA Study

JOANNE M. BARGMAN, KEVIN E. THORPE, DAVID N. CHURCHILL and ; the CANUSA Peritoneal Dialysis Study Group
JASN October 2001, 12 (10) 2158-2162;
JOANNE M. BARGMAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KEVIN E. THORPE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DAVID N. CHURCHILL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Abstract

Abstract. Studies of the adequacy of peritoneal dialysis and recommendations have assumed that renal and peritoneal clearances are comparable and therefore additive. The CANUSA data were reanalyzed in an effort to address this assumption. Among the 680 patients in the original CANUSA study, 601 had all of the variables of interest for this report. Adequacy of dialysis was estimated from GFR (mean of renal urea and creatinine clearance) and from peritoneal creatinine clearance. The Cox proportional-hazards model was used to evaluate the time-dependent association of these independent variables with patient survival. For each 5 L/wk per 1.73 m2 increment in GFR, there was a 12% decrease in the relative risk (RR) of death (RR, 0.88; 95% confidence interval [CI], 0.83 to 0.94) but no association with peritoneal creatinine clearance (RR, 1.00; 95% CI, 0.90 to 1.10). Estimates of fluid removal (24-h urine volume, net peritoneal ultrafiltration, and total fluid removal) then were added to the Cox model. For a 250-ml increment in urine volume, there was a 36% decrease in the RR of death (RR, 0.64; 95% CI, 0.51 to 0.80). The association of patient survival with GFR disappeared (RR, 0.99; 95% CI, 0.94 to 1.04). However, neither net peritoneal ultrafiltration nor total fluid removal was associated with patient survival. Although these results may be explained partly, statistically, by less variability in peritoneal clearance than in GFR, the latter seems to be physiologically more important than the former. The assumption of equivalence of peritoneal and renal clearances is not supported by these data. Recommendations for adequate peritoneal dialysis need to be reevaluated in light of these observations.

An association between greater clearance of small molecular weight solutes and better clinical outcomes in patients who are treated by continuous peritoneal dialysis has been reported in prospective cohort studies that have used multivariate statistical analysis (1,2). These and other studies have contributed to the adequacy of peritoneal dialysis recommendations proposed by the Dialysis Outcome Quality Initiative in the United States (3,4). These recommendations assume an equivalence between clearance of small molecules by the native kidneys and by the peritoneal membrane. However, these assumptions have been challenged in several recent publications (5,6,7,8). Davies et al. (5), from the United Kingdom, reported that for patients who are undergoing continuous ambulatory peritoneal dialysis with similar initial residual renal function, those who died had experienced a more rapid deterioration in renal function compared with survivors. Diaz-Buxo et al. (6), in a study from the United States, reported that residual renal function was strongly correlated with survival, whereas peritoneal clearance was not. Szeto et al. (7) found a strong association between greater GFR and survival but no association between peritoneal creatinine clearance and patient survival. Finally, Rocco et al. (8) reported a 40% decrease in the relative risk (RR) of death associated with a 10 L/wk per 1.73 m2 greater renal creatinine clearance and a 12% decrease in RR of death associated with a 1-unit greater weekly Kt/V. They found no associations between the RR of death with either peritoneal creatinine or urea clearance. Conversely, in a study of anuric patients who were undergoing peritoneal dialysis (9), there was much better survival among those who had a peritoneal Kt/V greater than 1.85 than for those with lower values.

In the CANUSA study (1), total (renal and peritoneal) solute clearance was found to correlate closely with morbid outcomes and with death. Specifically, an increase of 0.1 unit of Kt/V (peritoneal + renal) per week was associated with a 5% decrease in the RR of death, and an increase of 5 L/1.73 m2 of creatinine clearance per week (peritoneal + renal) was associated with a 7% decrease in the RR of death. Residual renal function declined over time but was not examined separately as a risk factor for clinical outcomes. The purpose of the current investigation was to analyze the unique contribution of residual renal function to the clinical outcomes reported in the CANUSA study.

Materials and Methods

The CANUSA study was a prospective cohort study performed in 14 centers in Canada and the United States. The methodology has been reported elsewhere (1).

Residual renal function in the present study was estimated from the GFR as calculated from the mean of urea and creatinine clearances (10). The contribution of peritoneal clearance to adequacy of dialysis was estimated from the peritoneal clearance of urea and of creatinine. Because the results were similar, the peritoneal clearance of creatinine was used in the present analysis.

The contribution of residual renal function to fluid balance was estimated from the 24-h urine volume collected at baseline and at 6-mo intervals. The contribution of peritoneal ultrafiltration was calculated from the net ultrafiltration (dialysate outflow minus prescribed inflow) per 24 h determined at enrollment and at 6 mo. Total fluid removal was the sum of urine volume and net peritoneal ultrafiltration. Other baseline variables that were determined were hemoglobin, serum calcium, phosphorus, CO2 content, and potassium.

The clinical outcome for this study was patient survival. Statistical analysis of patient mortality used Andersen and Gill's (11) extension to the Cox proportional-hazards model (12), with estimates of nutritional status, GFR, peritoneal clearance, urine volume, net peritoneal ultrafiltration, and total fluid removal as time-dependent covariates (13). Patient deaths were attributed to the level of the time-dependent covariate recorded at the 6-mo evaluation preceding the event. Transplantation, technique failure, and recovery of renal function were treated as censored observations. GFR and peritoneal creatinine clearance then were entered into the baseline model. Baseline variables that might be associated with GFR then were entered separately. Hemoglobin and serum calcium, phosphorus, potassium, and CO2 content were entered as surrogates for renal endocrine and excretory functions. The 24-h urine volume, 24-h net ultrafiltration, and 24-h total fluid removal then were entered to evaluate the role of fluid removal on patient survival. The likelihood-ratio test was used (14) to determine whether the addition of a variable added significantly to that model. Urine volume, net peritoneal ultrafiltration, and total fluid balance variables then were entered as time-dependent covariates. The validity of the proportional-hazards assumption was considered for all variables that remained in the final models by examination of the Schoenfeld residuals (15).

Results

Among the 680 patients who were enrolled in the original CANUSA report (1), 601 had all variables of interest that address the relative importance of GFR and peritoneal clearance. The mean age was 54.8 yr (SD 15.3); 59.9% were men, and 81.9% were white. The major causes for end-stage renal disease were diabetes mellitus (30.3%), glomerulonephritis (23.3%), and renal vascular disease/nephrosclerosis (20.3%). Among the 183 patients with diabetes mellitus, 83 had type I and 100 had type II. A total of 210 (34.9%) had a history of cardiovascular disease. At the baseline evaluation, 41 (6.8%) had low peritoneal membrane transport, 189 (31.4%) had low average transport, 278 (46.3%) had high average transport, and 93 (15.5%) had high peritoneal transport.

The weekly mean GFR, peritoneal creatinine clearance, 24-h urine volume, 24-h net peritoneal ultrafiltration, and 24-h total fluid removal at baseline and at 6, 12, 18, and 24 mo follow-up are shown in Table 1. The initial GFR was 37.7 L/wk per 1.73m2, and this decreased progressively to 14.8 by 24 mo of follow-up. The peritoneal creatinine clearance was 44.3 L/wk per 1.73 m2 at baseline, and this increased slightly to 47.2 by 24 mo of follow-up. The urine volume decreased from an initial 670 to 335 ml/24 h, whereas the net peritoneal ultrafiltration increased from 958 to 1951 ml/24 h.

View this table:
  • View inline
  • View popup
Table 1.

GFR, peritoneal creatinine clearance, and fluid removal at volumes baseline and at 6, 12, 18, and 24 months of follow-upa

The baseline Cox proportional-hazards model demonstrated an association of worse clinical outcomes with increased age, history of cardiovascular disease, lower serum albumin, lower subjective global assessment, and higher peritoneal membrane transport, as has been reported previously (1,16). A 5-L/wk greater total weekly creatinine clearance was associated with a 10% decrease in the RR of death (95% CI, 0.85 to 0.96). The total creatinine clearance was the sum of GFR and peritoneal creatinine clearance. The average of renal urea and creatinine clearance was used to mitigate the effect of renal tubular secretion of creatinine (10). Given that this secretion does not occur across the peritoneal membrane, the two types of clearance are considered to be comparable.

GFR and peritoneal creatinine clearance then were entered as separate time-dependent covariates. The Cox model is shown in Table 2. A 5-L greater weekly GFR is associated with a 12% decrease in the RR of death (95% CI, 0.83 to 0.94). There was no association between the same increase in peritoneal creatinine clearance and the RR of death (RR, 1.00; 95% CI, 0.90 to 1.11). Hemoglobin, serum calcium, serum phosphorus, serum potassium, and serum CO2 content, entered as surrogates of endocrine and other renal functions, did not add significantly to this statistical model.

View this table:
  • View inline
  • View popup
Table 2.

Cox model of relative risk of death with time-dependent Ccr divided into peritoneal clearance and GFR and entered as time-dependent covariatesa

The effect of adding urine volume is shown in Table 3. Addition of the 24-h urine volume as a time-dependent covariate to this model showed a marked association with the RR of death. For each increase of 250 ml of urine per day, there was a 36% decrease in the RR of death (RR, 0.64; 95% CI, 0.51 to 0.80). Addition of urine volume to this statistical model removed the association of GFR with survival (RR of death, 0.99; Table 3). However, when net peritoneal ultrafiltration per 24 h was added instead of 24-h urine volume, there was no association of this variable with the RR of death (RR, 1.04; 95% CI, 0.99 to 1.08). The peritoneal creatinine clearance remained nonsignificant (RR, 0.96), whereas the GFR again became significant (RR, 0.94; 95% CI, 0.90 to 0.99). Finally, when total fluid removal was used as the volume-related variable, there was no association with the RR of death (RR, 1.02; 95% CI, 0.97 to 1.06). An increase of 5 L/wk per 1.73 m2 in peritoneal creatinine clearance was not associated with the RR of death (RR, 0.99), whereas the same increase in GFR was associated with a 12% decrease in the RR of death (RR, 0.88).

View this table:
  • View inline
  • View popup
Table 3.

Cox model of relative risk for death with urine volume forced in as a time-dependent covariate

Discussion

In this analysis of the CANUSA data, the separate contributions of peritoneal clearance and renal clearance were evaluated. Previously, we demonstrated that total small solute clearance, both urea and creatinine, was a predictor of mortality in these patients (1). This reanalysis of the CANUSA data indicates that the contribution of residual renal function is much more important than peritoneal clearance.

Prospective studies by Maiorca et al. (2) and Davies et al. (5) of prevalent and incident patients have identified the important role of residual renal function in the survival of patients who are undergoing peritoneal dialysis. These observations are consistent with the association of more rapid loss of GFR with transfer to hemodialysis or with death, as observed in the CANUSA study (17), compared with those who received a renal transplant or who survived to the end of the study. However, it is possible that “sicker” patients lose residual renal function more rapidly and that this greater mortality occurs because they are sick, not because of the loss of residual renal function per se. Moist et al. (18) reported predictors of loss of residual renal function among new dialysis patients in the United States. Among the factors associated with an increased rate of loss of GFR in the patients who were undergoing peritoneal dialysis were diabetes mellitus and congestive heart failure, which suggests that patients who have more comorbidity experience a more rapid loss of residual renal function and that the increased risk of death is due to the comorbidity rather than to the loss of GFR. The studies reported from Italy (2) and the United Kingdom (5) do not address the possible confounding effect of these variables on the rate of loss of GFR and poorer patient survival. The studies from the United States by Diaz-Buxo et al. (6) and Rocco et al. (8) and from Hong Kong by Szeto et al. (7) used multivariate statistical analyses and demonstrated the beneficial association between greater GFR and better patient outcomes, adjusted for comorbidity. In a creatinine clearance model, there were worse outcomes associated with increased age and diabetes (6), with duration of dialysis and diabetes (7), and with age and diabetic end-stage renal disease (8). However, these studies were of prevalent patients (6,8) or a mixed prevalent-incident population (7). In two of these studies, there was relatively short follow-up: 1 yr (6) and 7 mo (8), respectively. None of these three studies evaluated change in GFR or peritoneal clearance as a time-dependent covariate, and the hypotheses generated in the discussions were not tested (6,7,8).

“Incidence-prevalence bias” introduces into observational studies a set of potential methodologic errors (19). Excepting the studies by Davies et al. (5) and the present study, all have used a cohort of prevalent (2,6,8) or mixed prevalent-incident patients (7) followed forward in time after cross-sectional ascertainment.

Another potential explanation for the lack of association between peritoneal clearance and patient survival is that higher peritoneal clearance may be associated with higher peritoneal membrane transport, which is associated with worse patient outcomes (16). These positively correlated variables have opposite associations with patient survival. We have found that the association of peritoneal membrane transport with patient outcome is not significantly changed when peritoneal creatinine clearance is added to the statistical model.

In general, the greater the range and variability of an independent variable (e.g., GFR, peritoneal creatinine clearance), the greater the statistical ability to detect a relationship with a dependent variable (e.g., patient survival). In the study by Diaz-Buxo et al. (5), the coefficient of variation of peritoneal clearance at initiation of follow-up of prevalent peritoneal dialysis patients was 29%. The range and variation for GFR were not provided but are described as being much greater than those for peritoneal creatinine clearance. In our study, the coefficient of variation for peritoneal creatinine clearance was 21%, compared with 70% for the GFR. The greater variability in the GFR, compared with that of peritoneal creatinine clearance, may be partly responsible for the detection of an association of GFR but not of peritoneal creatinine clearance with patient survival.

Greater residual renal function might be associated with better preserved renal endocrine function. Addition of baseline hemoglobin as a surrogate for erythropoietin and baseline serum calcium as a surrogate for 1-α hydroxylation of vitamin D3 did not add significantly to the statistical model. Similarly, serum phosphate, potassium, and bicarbonate as estimates of other renal excretory functions showed no association with patient survival.

The advantage conferred by preserved residual renal function may relate to the volume of urine excreted and the maintenance of euvolemic status. Increasing attention is being paid to the role of fluid overload in the precipitation of congestive heart failure. The apparent survival advantage of residual renal function may be due to the volume of urine excreted with mitigation of chronic fluid overload. In this study, when 24-h urine volume was examined as a time-dependent covariate, there was a marked correlation between preserved urine volume and a reduction in the RR of death. For each additional 250 ml of urine excreted per day, the RR of death was decreased by 36% (Table 3). Addition of urine volume to this model caused the association between GFR and survival to become nonsignificant, which suggests that the effect of GFR might be mediated by urine volume. However, if urine volume supersedes GFR, then one would expect that total fluid removal (the sum of urine volume and net peritoneal ultrafiltration) should be even more important. However, neither net peritoneal ultrafiltration nor total fluid removal per 24 h showed an association with mortality. The lack of association of peritoneal ultrafiltration volume with outcome may be confounded by the peritoneal transport status; that is, a low transporter would be expected to have greater volume of peritoneal fluid removal and a better outcome (16). By using both transport status and peritoneal ultrafiltration in the multivariate analysis, we might be obscuring the effect of the latter. However, when transport status is removed as a variable of interest, we were still unable to show that peritoneal ultrafiltration predicted outcome (data not shown). In those statistical models, the GFR became significant once again. Therefore, the beneficial association between GFR and outcome does not seem to be related simply to fluid removal. The failure to identify an association between net peritoneal ultrafiltration and patient survival cannot be explained on the basis of less variability compared with urine volume, because the coefficient of variation was similar for the two (83 versus 78%).

The contribution of residual renal function may be biologically more important compared with that of peritoneal clearance, in part because of better clearance of middle and larger molecular weight uremic toxins. As an example, Mamoun et al. (20) demonstrated in a rat model that substances with a molecular weight range from 1.0 to 5.0 kD, isolated from uremic plasma, are associated with anorexia. At this molecular weight range, the peritoneal clearance would be poor compared with that achieved by renal excretion.

In the CANUSA study (1), no attempt was made to replace loss of residual renal clearance with increased peritoneal clearance. However, the value of peritoneal clearance has been demonstrated in anuric patients. There is a clinically important but statistically nonsignificant improved patient survival for those with peritoneal Kt/V values greater than 1.85/wk (9). Davies et al. (21), in a study of malnourished patients who were undergoing peritoneal dialysis, increased peritoneal Kt/V because of a continued loss of residual renal function. They reported a modest nutritional benefit in patients without comorbidity.

In summary, the original CANUSA data showed an association of total small solute clearance, both urea and creatinine, with patient survival (1). However, when solute clearance is subdivided into that contributed by peritoneal clearance and that from residual renal function, it is the latter that appears to be much more important. This does not seem to be the result of an association of loss of GFR with more severe comorbidity. It may be explained partially by less variability in peritoneal than in renal clearances. The worse patient survival associated with loss of GFR also may be the result of decreased clearance of both small and larger molecular weight uremic toxins and, in part, to loss of renal contribution to the maintenance of euvolemia. When GFR declines, patients should be reviewed very carefully for evidence of uremia, hypervolemia, and malnutrition. The critical GFR level has not been defined but probably is that reached after 2 to 3 yr of peritoneal dialysis treatment, when the survival advantage of peritoneal dialysis over hemodialysis is lost (22).

Acknowledgments

This work was supported by the Kidney Foundation of Canada; Baxter Healthcare in Canada and the United States; the Father Sean O'Sullivan Research Center (Hamilton, Ontario, Canada); the Kidney Foundation of Manitoba, Foothills Hospital Research and Development Committee (Calgary, Alberta, Canada); Nephrology Research Fund Victoria Hospital (Halifax, Nova Scotia, Canada); and the Dialysis Research Fund, Toronto General Division of the Toronto Hospital (Toronto, Ontario, Canada).

Footnotes

  • Members of the CANUSA Peritoneal Dialysis Study Group

  • D. N. Churchill, D. W. Taylor, K. E. Thorpe, and M. L. Beecroft, St Joseph's Hospital, McMaster University, Hamilton, Ontario; P. R. Keshaviah, G. deVeber, and L. W. Henderson, Baxter Healthcare; K. K. Jindal, Victoria General Hospital, Halifax, Nova Scotia; S. S. A. Fenton, J. M. Bargman, and D. G. Oreopoulos, The Toronto Hospital, University of Toronto, Toronto, Ontario; G. G. Wu, Credit Valley Hospital, Mississauga, Ontario; S. D. Lavoie, Ottawa Civic Hospital, University of Ottawa, Ottawa, Ontario; A. Fine, St. Boniface Hospital, University of Manitoba, Winnipeg, Mannitoba; E. Burgess, Foothills Hospital, University of Calgary, Calgary, Alberta; J. C. Brandes, Medical College of Wisconsin, Milwaukee, Wisconsin; K. D. Nolph and B. F. Prowant, University of Missouri Medical Center, Columbia, Missouri; D. Pagé, Ottawa General Hospital, University of Ottawa, Ottawa, Ontario; F. X. McCusker and BP Teehan, Lankenau Hospital, Thomas Jefferson Medical College, Philadelphia, Pennsylvania; M. K. Dasgupta and K. Bettcher, University of Alberta Hospital, University of Alberta, Edmonton, Alberta; and R. Caruana, Medical Colledge of Georgia, Augusta, Georgia.

  • © 2001 American Society of Nephrology

References

  1. ↵
    Churchill DN, Taylor DW, Keshaviah PR for the CANUSA Peritoneal Dialysis Study Group: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 7: 198 -207, 1996
    OpenUrlAbstract
  2. ↵
    Maiorca R, Brunori G, Zubani R, Cancarini GC, Manili L, Camerini C, Movilli E, Pola A, d'Avolio G, Gelatti U: Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients: A longitudinal study. Nephrol Dial Transplant 10: 2295 -2305, 1995
    OpenUrlPubMed
  3. ↵
    NKF-DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy. New York, National Kidney Foundation, 1997 , pp 45-48
  4. ↵
    National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy, 2000. Am J Kidney Dis 37 [Suppl 1]: S65-S136, 2001
    OpenUrlCrossRefPubMed
  5. ↵
    Davies SJ, Phillips L, Russell GI: Peritoneal solute transport predicts survival on CAPD independently of residual renal function. Nephrol Dial Transplant 13: 962 -968, 1998
    OpenUrlCrossRefPubMed
  6. ↵
    Diaz-Buxo JA, Lowrie EG, Lew NL, Zhang H, Zhu X, Lazarus JM: Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance. J Am Soc Nephrol 33: 523 -534, 1999
    OpenUrl
  7. ↵
    Szeto C-C, Wong TY-H, Leung C-B, Wang AY-M, Law M-C, Lui S-F, Li PK-T: Importance of dialysis adequacy in mortality and morbidity of Chinese patients. Kidney Int 58: 400 -407, 2000
    OpenUrlCrossRefPubMed
  8. ↵
    Rocco M, Soucie JM, Pastan S, McClellan WM: Peritoneal dialysis adequacy and risk of death. Kidney Int 58 : 446-457, 2000
    OpenUrlCrossRefPubMed
  9. ↵
    Bhaskaran S, Schaubel DE, Jassal SV, Thodis E, Singhal MK, Bargman JM, Vas SI, Oreopoulos DG: The effect of small solute clearance on survival of anuric peritoneal dialysis patients. Perit Dial Int 20 : 181-187, 2000
    OpenUrlAbstract/FREE Full Text
  10. ↵
    van Olden RW, Krediet RT, Struijk DG, Arisz L: Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 7 : 745-750, 1996
    OpenUrlAbstract
  11. ↵
    Anderson PK, Gill RD: Cox's regression model for counting processes: A large sample study. Ann Stat 10 : 1100-1120, 1982
    OpenUrlCrossRef
  12. ↵
    Cox D: Regression models and life tables. J R Stat Soc 34: 187-201, 1972
    OpenUrl
  13. ↵
    Kalbfleisch JD, Prentice RL: The Statistical Analysis of Survival Time Data. New York, Wiley, 1980, 122 -127
  14. ↵
    Cox DR, Oakes D: Analysis of Survival Data. London, Chapman and Hall, 1984
  15. ↵
    Schoenfeld D: Partial residuals for the proportional hazards regression model. Biometrika 69 : 239-241, 1982
    OpenUrlCrossRef
  16. ↵
    Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D: Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J Am Soc Nephrol 9: 1285 -1292, 1998
    OpenUrlAbstract
  17. ↵
    Misra M, Vonesh E, Churchill DN, Moore HL, Van Stone JC, Nolph KD: Preservation of glomerular filtration rate on dialysis when adjusted for patient dropout. Kidney Int 57: 691 -606, 2000
    OpenUrlCrossRefPubMed
  18. ↵
    Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, Hulbert-Shearon T, Jones CA, Bloembergen WE: Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 11: 56 -564, 2000
  19. ↵
    Sackett DL: Bias in analytic research. J Chron Dis 32: 51-63, 1979
    OpenUrlCrossRefPubMed
  20. ↵
    Mamoun AH, Sodersten P, Anderstam B, Bergstrom J: Evidence of splanchnic-brain signaling in inhibition of ingestive behaviour by middle molecules. J Am Soc Nephrol 10: 309 -314, 1999
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Davies SJ, Phillips L, Griffiths AM, Naish PF, Russell GI: Analysis of the effects of increasing delivered dialysis treatment to malnourished peritoneal dialysis patients. Kidney Int 57 : 1743-1754, 2000
    OpenUrlCrossRefPubMed
  22. ↵
    Fenton SS, Schaubel DE, Desmeules M, Morrison HI, Moo Y, Copleston P, Jeffery JR, Kjellstrand CM: Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates. Am J Kidney Dis 30: 334-342, 1997
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 12 (10)
Journal of the American Society of Nephrology
Vol. 12, Issue 10
1 Oct 2001
  • Table of Contents
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
Relative Contribution of Residual Renal Function and Peritoneal Clearance to Adequacy of Dialysis: A Reanalysis of the CANUSA Study
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Relative Contribution of Residual Renal Function and Peritoneal Clearance to Adequacy of Dialysis: A Reanalysis of the CANUSA Study
JOANNE M. BARGMAN, KEVIN E. THORPE, DAVID N. CHURCHILL
JASN Oct 2001, 12 (10) 2158-2162;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Relative Contribution of Residual Renal Function and Peritoneal Clearance to Adequacy of Dialysis: A Reanalysis of the CANUSA Study
JOANNE M. BARGMAN, KEVIN E. THORPE, DAVID N. CHURCHILL
JASN Oct 2001, 12 (10) 2158-2162;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • Relative Contribution of Residual Renal Function and Different Measures of Adequacy to Survival in Hemodialysis Patients: An analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2
  • Features of Chronic Hemodialysis Practice after the Marmara Earthquake
  • The Relationship Between Systemic and Whole-Body Hematocrit Is Not Constant during Ultrafiltration on Hemodialysis
Show more Dialysis

Cited By...

  • Contrast media in patients with kidney disease: An update
  • Association of Tubular Solute Clearance with Symptom Burden in Incident Peritoneal Dialysis
  • Removal of Protein-Bound Uremic Toxins by Liposome-Supported Peritoneal Dialysis
  • Higher eGFR at Dialysis Initiation Is Not Associated with a Survival Benefit in Children
  • Can Lower Dialysate Sodium Concentrations Contribute to Blood Pressure Control in Peritoneal Dialysis?
  • Computer Simulations of Continuous Flow Peritoneal Dialysis Using the 3-Pore Model--A First Experience
  • Assessment and Management of Hypertension among Patients on Peritoneal Dialysis
  • Association of Continuation of Loop Diuretics at Hemodialysis Initiation with Clinical Outcomes
  • Early Peritoneal Dialysis Technique Failure: Review
  • Residual Function Effectively Controls Plasma Concentrations of Secreted Solutes in Patients on Twice Weekly Hemodialysis
  • Current Uses of Dietary Therapy for Patients with Far-Advanced CKD
  • Rapid Change in Residual Renal Function Decline Is Associated with Lower Survival and Worse Residual Renal Function Preservation in Peritoneal Dialysis Patients
  • The Use of a Multidimensional Measure of Dialysis Adequacy--Moving beyond Small Solute Kinetics
  • Predictors of Residual Renal Function Decline in Peritoneal Dialysis Patients: The balANZ Trial
  • Prognostic Value of Residual Urine Volume, GFR by 24-hour Urine Collection, and eGFR in Patients Receiving Dialysis
  • Preservation of Residual Kidney Function and Urine Volume in Patients on Dialysis
  • Kinetic Modeling of Incremental Ambulatory Peritoneal Dialysis Exchanges
  • Association of Alternative Approaches to Normalizing Peritoneal Dialysis Clearance with Mortality and Technique Failure: A Retrospective Analysis Using the United States Renal Data System-Dialysis Morbidity and Mortality Study, Wave 2
  • Preserving Residual Kidney Function in Hemodialysis Patients--Back in the Spotlight
  • Residual Kidney Function Decline and Mortality in Incident Hemodialysis Patients
  • Risk Factors for Decline of Residual Renal Function in Children Treated With Peritoneal Dialysis
  • The Current State of Peritoneal Dialysis
  • Does Changing the Volume Matter? The Relationship of Urine Volume and Dialysis Intensity
  • Hydration Status of Patients Dialyzed with Biocompatible Peritoneal Dialysis Fluids
  • Is the Effect of Low-GDP Solutions on Residual Renal Function Mediated by Fluid State? An Enigmatic Question which Still Needs to be Solved
  • Evaluating Hyponatremia in Non-Diabetic Uremic Patients on Peritoneal Dialysis
  • A Patient on Peritoneal Dialysis with Refractory Volume Overload
  • Serum Cystatin C Does Not Predict Mortality or Treatment Failure in Peritoneal Dialysis: A Prospective Study
  • Pharmacokinetic and Dynamic of Furosemide in Peritoneal Dialysis Patients
  • The Impact of Timing of Dialysis Initiation on Mortality in Patients with Peritoneal Dialysis
  • Predicting Risk in Peritoneal Dialysis: Is Membrane Biology Destiny?
  • A Pilot Study Examining the Effects of Tolvaptan on Residual Renal Function in Peritoneal Dialysis for Diabetics
  • Effect of Neutral-pH, Low-Glucose Degradation Product Peritoneal Dialysis Solutions on Residual Renal Function, Urine Volume, and Ultrafiltration: A Systematic Review and Meta-Analysis
  • Uncorrected and Albumin-Corrected Calcium, Phosphorus, and Mortality in Patients Undergoing Maintenance Dialysis
  • The Impact of Transfer from Hemodialysis on Peritoneal Dialysis Technique Survival
  • Risk Factors for Mortality in Chinese Patients on Continuous Ambulatory Peritoneal Dialysis
  • Comparison of the Impact of "Fast Decline" in Residual Renal Function and "Initial Anuria" on Long-Term Outcomes in CAPD Patients
  • Utility of Urinary Biomarkers in Predicting Loss of Residual Renal Function: The balANZ Trial
  • Effect of Biocompatible Peritoneal Dialysis Solution on Residual Renal Function: A Systematic Review of Randomized Controlled Trials
  • Serum Concentrations of p-Cresyl Sulfate and Indoxyl Sulfate, but Not Inflammatory Markers, Increase in Incident Peritoneal Dialysis Patients in Parallel with Loss of Residual Renal Function
  • Clinical Experience Using Bioimpedance to Optimize Blood Pressure Control
  • Dialysis Modality and Correction of Uremic Metabolic Acidosis: Relationship with All-Cause and Cause-Specific Mortality
  • Association of Modality with Mortality among Canadian Aboriginals
  • Effect of Timing of Dialysis Commencement on Clinical Outcomes of Patients with Planned Initiation of Peritoneal Dialysis in the Ideal Trial
  • Serum {beta}-Trace Protein and Risk of Mortality in Incident Hemodialysis Patients
  • Serum Potassium and Cause-Specific Mortality in a Large Peritoneal Dialysis Cohort
  • Effluent Free Radicals are Associated with Residual Renal Function and Predict Technique Failure in Peritoneal Dialysis Patients
  • Effects of Biocompatible versus Standard Fluid on Peritoneal Dialysis Outcomes
  • Residual Renal Function Calculated from Serum Cystatin C Measurements and Knowledge of the Weekly Standard Kt/V Urea
  • The Effect of Racial Origin on Total Body Water Volume in Peritoneal Dialysis Patients
  • N-Acetylcysteine Improves Residual Renal Function in Peritoneal Dialysis Patients: A Pilot Study
  • Selection Bias Explains Apparent Differential Mortality between Dialysis Modalities
  • Early Start of Dialysis: A Critical Review
  • Benfotiamine Protects against Peritoneal and Kidney Damage in Peritoneal Dialysis
  • Assessing Creatinine Clearance from Modification of Diet in Renal Disease Study Equations in the ADEMEX Cohort: Limitations and Potential Applications
  • Volume Status in Peritoneal Dialysis
  • CLINICAL PRACTICE GUIDELINES AND RECOMMENDATIONS ON PERITONEAL DIALYSIS ADEQUACY 2011
  • Contribution of Residual Function to Removal of Protein-Bound Solutes in Hemodialysis
  • Role of Residual Renal Function in Phosphate Control and Anemia Management in Chronic Hemodialysis Patients
  • TREATMENT WITH ANGIOTENSIN II INHIBITORS AND RESIDUAL RENAL FUNCTION IN PERITONEAL DIALYSIS PATIENTS
  • CYSTATIN C MEASUREMENTS IN THE ASSESSMENT OF RESIDUAL RENAL FUNCTION, DIALYSIS ADEQUACY, AND BEYOND
  • Residual Renal Function in Peritoneal Dialysis After Renal Transplant Failure
  • Strategies for Improving Long-Term Survival in Peritoneal Dialysis Patients
  • ON SMALL SOLUTE CLEARANCE AND PATIENT OUTCOMES: EVIDENTIAL PRACTICE OR OBSERVATIONAL TREPIDATION?
  • PERITONEAL SMALL SOLUTE CLEARANCE IS NONLINEARLY RELATED TO PATIENT SURVIVAL IN THE AUSTRALIAN AND NEW ZEALAND PERITONEAL DIALYSIS PATIENT POPULATIONS
  • ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PERITONEAL DIALYSIS: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
  • Comparison of Volume Overload with Cycler-Assisted versus Continuous Ambulatory Peritoneal Dialysis
  • PREVIOUS COMORBIDITY AND LACK OF PATIENT FREE CHOICE OF TECHNIQUE PREDICT EARLY MORTALITY IN PERITONEAL DIALYSIS
  • PERITONEAL DIALYSIS AND PRESERVATION OF RESIDUAL RENAL FUNCTION
  • Advances and innovations in dialysis in the 21st century
  • Predictive Value of Brain Natriuretic Peptides in Patients on Peritoneal Dialysis: Results from the ADEMEX Trial
  • Is the Declining Use of Long-Term Peritoneal Dialysis Justified by Outcome Data?
  • Administration of Tobramycin in the Beginning of the Hemodialysis Session: A Novel Intradialytic Dosing Regimen
  • 30 YEARS OF PERITONEAL DIALYSIS DEVELOPMENT: THE PAST AND THE FUTURE
  • THERAPEUTIC OPTIONS FOR PRESERVATION OF RESIDUAL RENAL FUNCTION IN PATIENTS ON PERITONEAL DIALYSIS
  • THE "HEART" OF PERITONEAL DIALYSIS
  • CLINICAL EFFECTS OF COMBINED THERAPY WITH PERITONEAL DIALYSIS AND HEMODIALYSIS
  • CARDIOVASCULAR RISK FACTORS IN PERITONEAL DIALYSIS PATIENTS REVISITED
  • Google Scholar

Similar Articles

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire